Recombumin®
The Recombumin® product portfolio consists of commercially available, high-quality, animal and human-origin-free recombinant human albumins. Our recombinant human albumins are multi-functional excipients, ancillaries and raw materials, that offer stabilizing properties that have been validated through long-established use in multiple marketed life science products.
Our high purity, safe, and consistent Recombumin® recombinant human albumins support an array of life science applications, including advanced therapies, at every stage of their journey from research and development to in-human application.
*Custom/bulk order quotes are provided within 72 hours of request.
Choose your product
Products (5)
Our Recombumin® recombinant human albumin portfolio is produced in a proprietary yeast strain and is the culmination of four decades of recombinant albumin research. The Recombumin® portfolio is made up of two recombinant human albumin formulations: Recombumin® Prime and Recombumin® Elite.
Manufactured in an ICH Q7 cGMP facility, our Recombumin® portfolio offers your process batch-to-batch consistency and predictable performance. Utilized in FDA, EMEA and MHRA approved products, early and late-stage clinical biopharmaceutical candidates, and as a coating for marketed high-class medical devices, the Recombumin® portfolio has excellent market exposure. With an extensive regulatory package and drug master files registered in key markets, the Recombumin® portfolio is a solution for those developing high-quality products, that demand high quality and consistent raw materials.
We know that the formulation of your albumin really matters, as the manufacturing process and the ligands associated with albumin drive differential performance. Use the experience and know-how of our Sartorius team to help make your project a success!
Recombumin® Elite | Key Facts
- Salt-based recombinant human albumin formulation
- Recombumin® Elite is used both up and downstream in several advanced therapies currently in development.
- Recombumin® Elite has an extensive DMF registered in key markets.
Recombumin® Prime | Key Facts
- Octanoate and polysorbate-80 based recombinant human albumin formulation.
- Recombumin® Prime has supported the manufacture of over 210 million doses of paediatric vaccine.
- Recombumin® Prime is utilized in the manufacture of medical devices, forming an anti-adsorptive biological interface.
- Recombumin® Prime (50 mL) is USP-NF compliant.